NSE - Delayed Quote INR
Cohance Lifesciences Limited (SUVENPHAR.NS)
1,063.30
-14.50
(-1.35%)
At close: 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
3,584,831
4,571,958
3,300,002
3,825,465
Investing Cash Flow
--
-3,622,532
-1,950,056
-1,361,383
-3,113,982
Financing Cash Flow
--
-138,023
-2,419,512
-1,564,807
-756,617
End Cash Position
--
472,312
648,028
445,638
71,822
Capital Expenditure
--
-517,869
-2,859,122
-751,867
-1,108,460
Free Cash Flow
--
3,066,962
1,712,836
2,548,135
2,717,005
3/31/2021 - 3/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SUVEN.NS Suven Life Sciences Limited
153.07
+7.46%
HESTERBIO.BO Hester Biosciences Limited
1,744.20
+5.85%
JBCHEPHARM.BO J. B. Chemicals & Pharmaceuticals Limited
1,561.90
+2.27%
SYNCOMF.BO Syncom Formulations (India) Limited
16.44
+9.24%
NEULANDLAB.BO Neuland Laboratories Limited
12,550.75
+0.93%
ERIS.NS Eris Lifesciences Limited
1,404.90
-3.51%
ASTRAZEN.NS AstraZeneca Pharma India Limited
8,119.50
+1.87%
LAURUSLABS.BO Laurus Labs Limited
592.90
+0.68%
GLAND.NS Gland Pharma Limited
1,430.10
+0.29%
SHILPAMED.NS Shilpa Medicare Limited
650.75
+1.85%